Posted by Michael Wonder on 30 Aug 2021
Zimmer Biomet and Canary Medical announce FDA de novo classification grant and authorisation to market the world's first and only smart knee implant
30 August 2021 - Post-operative gait metrics to provide real world, objective patient data.
Zimmer Biomet Holdings today announced U.S. FDA de novo classification grant and authorisation to market the tibial extension for Persona IQ, the world's first and only smart knee cleared by the FDA for total knee replacement surgery.
Persona IQ combines Zimmer Biomet's proven and trusted knee implant, Persona The Personalized Knee, with Canary Medical's proprietary implantable canturio te tibial extension sensor technology that measures and determines range of motion, step count, walking speed and other gait metrics.
